Special edition of the FSA-Transparency-Newsletter regarding the publication of payments by pharmaceutical companies to members of the healthcare field now online - FSA in a discussion with two physicians which decided to have their data published.
Selected Media Response to the Transparency Code
The Communication regarding the publication of the financial contribution physicians receive from pharmaceutical companies has triggered a wide media echo during June and July 2016 and initiated a broad discussion all over Germany.
Info graphics on the public disclosures within the scope of the Transparency Code
54 pharmaceutical companies, representing 75% of the German market for ethical drugs, published their 2015 payments to physicians, healthcare professionals, medical organizations and institutions.
Transparency creates trust and combats mistrust!
- The collaboration between pharma companies and members of the medical profession is vital and necessary.
- It promotes patient well-being and the continuous improvement of his medical care.
- That is why there are explicit provisions, laws and codes of conduct that clearly regulate collaboration for both sides.
- Through transparency in collaboration, the appearance of conflicts of interest can be prevented at the onset.